TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 47 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $12,628,000 | +3.8% | 119,960 | +8.9% | 0.00% | 0.0% |
| Q3 2016 | $12,169,000 | -18.1% | 110,119 | +7.9% | 0.00% | -33.3% |
| Q2 2016 | $14,853,000 | +86.3% | 102,011 | +83.3% | 0.00% | +50.0% |
| Q1 2016 | $7,972,000 | +1.6% | 55,651 | +9.6% | 0.00% | 0.0% |
| Q4 2015 | $7,847,000 | +112000.0% | 50,772 | +105675.0% | 0.00% | – |
| Q3 2014 | $7,000 | 0.0% | 48 | -5.9% | 0.00% | – |
| Q2 2014 | $7,000 | +16.7% | 51 | 0.0% | 0.00% | – |
| Q1 2014 | $6,000 | +20.0% | 51 | 0.0% | 0.00% | – |
| Q4 2013 | $5,000 | -98.4% | 51 | -98.7% | 0.00% | – |
| Q3 2013 | $304,000 | +54.3% | 4,003 | +13.5% | 0.00% | – |
| Q2 2013 | $197,000 | – | 3,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |